Alzheimer's patients test drug for over a year in extended safety study
NCT ID NCT05522387
Summary
This study aimed to check the long-term safety and effects of an experimental drug called XPro1595 in people with Alzheimer's disease. It was an extension for 11 people who had already taken the drug in an earlier trial. Participants received a weekly injection for up to 18 months while researchers monitored their health, memory, and daily function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Health
Ivanhoe, Victoria, 3079, Australia
-
Australian Alzheimer's Research Foundation
Perth, Western Australia, 6009, Australia
-
KaRa MINDS
Macquarie Park, New South Wales, 2113, Australia
-
Neuro Trials Victoria Pty Ltd T/A NeuroCentrix
Carlton, Victoria, 3053, Australia
Conditions
Explore the condition pages connected to this study.